Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 59,968 shares at $104.56 ($6.3M) on 2020-02-10, disclosed to the SEC on 2020-02-11.
Seasonal sale ($6.3M) by Chief Regulatory Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.28 | 1,015 | $105K | 1.7% |
| 2 | $103.28 | 1,015 | $105K | 1.7% |
| 3 | $104.56 | 13,042 | $1.4M | 21.8% |
| 4 | $104.56 | 13,042 | $1.4M | 21.8% |
| 5 | $104.56 | 15,927 | $1.7M | 26.6% |
| 6 | $104.56 | 15,927 |
| $1.7M |
| 26.6% |
| Total | $104.52 avg | 59,968 | $6.3M | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |